| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |